Related Experiment Video
Updated: Mar 26, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
[Infective endocarditis in adult patients with congenital heart disease. Experience from a reference centre]
Jose Loureiro-Amigo1, Nuria Fernández-Hidalgo2, Antonia Pijuan-Domènech3
1Servicio de Medicina Interna, Hospital Universitario Vall d'Hebron, Barcelona, España.
Insights
Infective endocarditis (IE) in adults with congenital heart disease (CHD) often affects young patients with prosthetic material or residual defects, frequently on the right side. While surgery is common, mortality is low unless relapses occur.
Area of Science:
- Cardiology
- Infectious Diseases
- Adult Congenital Heart Disease
Background:
- Increasing adult population with congenital heart disease (CHD).
- Infective endocarditis (IE) is a significant complication in adults with CHD.
- Limited data on IE features in this specific demographic.
Purpose of the Study:
- To describe the clinical features of infective endocarditis (IE) in adult patients with congenital heart disease (CHD).
- To identify common etiologies, affected cardiac structures, and treatment outcomes.
- To inform management strategies for IE in this growing patient population.
Main Methods:
- Retrospective review of adult patients (≥16 years) with CHD and IE (modified Duke criteria) from 1996-2014.
- Analysis focused on the first IE episode per patient.
- Descriptive statistics to characterize patient demographics, CHD types, IE presentation, and outcomes.
Main Results:
- 27 adult CHD patients diagnosed with IE; median age 27.7 years, predominantly male (63%).
- Most common CHD: ventricular septal defect (33%); 41% had prosthetic material, 81% had residual defects.
- Right-sided IE (44%) was frequent, with viridans group streptococci and Staphylococcus epidermidis as primary pathogens.
- Surgery required in 37%; mortality was low (2 patients), primarily due to recurrence.
Conclusions:
- IE in adults with CHD typically affects young individuals with prosthetic material or residual defects.
- Right-sided IE is common, and while surgical intervention is often necessary, overall mortality is low.
- Relapses pose a significant risk, highlighting the need for vigilant follow-up and management.
Introduction:
A growing number of patients with congenital heart disease (CHD) will reach adulthood. Infective endocarditis (IE) is a major complication in this population. The aim of this study was to describe the features of IE in adults with CHD treated in a reference centre.
Methods:
A retrospective review was performed on a cohort of patients over 16 years of age with CHD who presented with IE (defined by the modified Duke criteria) between 1996 and 2014. Only the first episode from each patient was considered for the descriptive analysis.
Results:
IE was observed in 27 patients. The median age at diagnosis of IE was 27.7 years, and 63% were male. Comorbidity was low (median Charlson index was 0). IE was mostly community-acquired (78%). The most frequent CHD were ventricular septal defect (33%). A repair was performed in 48% of patients, and 19% received palliative treatment. Forty-one percent of patients had some type of prosthesis. A residual defect was observed in 81%. The IE was detected in the right side of 44% of the patients. The most frequent aetiological agents were viridans group streptococci (41%) and Staphylococcus epidermidis (30%). Surgery was required to treat IE in 37% of patients. There were five re-infections and three relapses. Two patients died, both as a result of recurrence.
Conclusions:
IE in adults with CHD occurred in young patients, and almost all of them carried some prosthetic material or a residual defect. The IE is frequently right-sided. Although surgical treatment was required in many cases, mortality was low, except in the case of relapses.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis IV: Nursing Management
Rheumatic Heart Disease I: Introduction
Myocarditis III: Medical Management

